PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates

Lignende værker

• Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study
  af: Dong, Jennifer Q, et al.
  Udgivet: (2015)
• Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice.
  af: Yan Weng, et al.
  Udgivet: (2015-01-01)
• Pharmacokinetics (PK), Pharmacodynamics (PD) and Integrated PK/PD Modeling of a Novel Long Acting FGF21 Clinical Candidate PF-05231023 in Diet-Induced Obese and Leptin-Deficient Obese Mice
  af: Weng, Yan, et al.
  Udgivet: (2015)
• FGF19 and FGF21: In NASH we trust
  af: Talukdar, Saswata, et al.
  Udgivet: (2020)
• Long-Acting FGF21 Inhibits Retinal Vascular Leakage in In Vivo and In Vitro Models
  af: Tomita, Yohei, et al.
  Udgivet: (2020)